Sao Paulo State University   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Sao Paulo Brazil (1976)

Organization Overview

First Clinical Trial
2002
NCT00910442
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Alagoas State University of Health Science , Maceió , Brazil. | ao Paulo State University "Julio de Mesquita Filho" | Biophisics Department of Biosciences Institute - Unesp | Botucatu Medicine School - Sao Paulo State University | Escola Paulista de Medicina | Flávia Carvalho | Fundacao Universidade de Ciencias da Saude de Alagoas Governador Lamenha Filho | Fundacao Universidade de Ciencias da Saude de Alagoas Governador Lamenha Filho / UNCISAL | ICT-UNESP | Paulista State University | Paulista University | Sao Paulo States University - Brazil | Sao Paulo State University | São Paulo State University | Sao Paulo State University - Brazil | Sao Paulo State University "Julio de Mesquita Filho" | Sao Paulo State University "Julio de Mesquita Filho", Faculdade de Ciências Farmacêuticas | Sao Paulo State University "Julio de Mesquita Filho", Faculty of Pharmaceutical Sciences | São Paulo State University (Unesp) | Thais Cesar | UNESP - Botucatu Medical School | UNESP Medical School | UNIFESP-EPM | UNIFESP/EPM | UNIFESP Instituto de Oncologia Pediatrica | Universidade Estadual de Ciências da Saúde de Alagoas | Universidade Estadual Júlio de Mesquita Filho | Universidade Estadual Paulista | Universidade Estadual Paulista - FCT / UNESP | Universidade Estadual Paulista "Julho de Mesquita Filho" (UNESP) | Universidade Estadual Paulista Julio de Mesquita Filho | Universidade Estadual Paulista Júlio de Mesquita Filho | Universidade Estadual Paulista Julio de Mesquita Filho, ICT/UNESP | Universidade Estadual Paulista - UNESP | Universidade Estadual Paulista - UNESP - Campus de Presidente Prudente | University of Estadual Paulista | University of Paulista State | University of Paulista State - Julio de Mesquita Filho, UNESP | University of São Paulo State, UNESP | Univ Estadual Paulista (UNESP) | Unversidade Estadual Paulista | UPECLIN HC FM Botucatu Unesp

Active Ingredients

Drugs in Phase 4 Trials (26)

acetaminophen (tylenol) (1 trial)

carvedilol (coreg) (1 trial)

ceftriaxone (rocephin) (1 trial)

cetirizine (zyrtec) (1 trial)

chlorhexidine (hibitane) (3 trials)

clavulanate (Augmentin) (1 trial)

collagen (1 trial)

connective tissue graft (2 trials)

efavirenz (sustiva) (1 trial)

gabapentin (neurontin) (2 trials)

glucose (2 trials)

isoflurane (forane) (2 trials)

lopinavir (Kaletra) (1 trial)

metoprolol (lopressor) (1 trial)

midazolam (versed) (1 trial)

nifedipine (procardia) (1 trial)

oxacillin (pathocil) (1 trial)

polidocanol (asclera) (2 trials)

procaine benzylpenicillin (novocaine) (5 trials)

propofol (diprivan) (2 trials)

ritonavir (Norvir) (1 trial)

simvastatin (zocor) (1 trial)

spironolactone (aldactone) (1 trial)

sufentanil (1 trial)

testosterone (delatestryl) (1 trial)

tramadol (Ultram) (1 trial)

Drugs in Phase 3 Trials (7)

acetylsalicylic acid (aspirin) (3 trials)

clarithromycin (biaxin) (3 trials)

icosapent ethyl (vascepa) (3 trials)

idursulfase (elaprase) (1 trial)

lidocaine (xylocaine) (1 trial)

metronidazole (flagyl) (3 trials)

tannic acid (1 trial)

Drugs in Phase 2 Trials (10)

beclomethasone (vanceril) (1 trial)

calcium hydroxide (1 trial)

formoterol (foradil) (1 trial)

glutathione (1 trial)

glycopyrronium (robinul) (1 trial)

green propolis (1 trial)

heparin (liquaemin) (1 trial)

isotretinoin (Accutane) (1 trial)

nystatin (mycostatin) (1 trial)

tretinoin (Retin-A) (1 trial)

Drugs in Phase 1 Trials (4)

curcumin (1 trial)

gentamicin (garamycin) (1 trial)

nitrous oxide (1 trial)

oxygen (1 trial)

Drugs in Other Trials (17)

azelaic acid (azelex) (1 trial)

bone marrow derived mononuclear cells (1 trial)

caffeine (1 trial)

copolymer (1 trial)

drospirenone (Yasmin) (1 trial)

eriocitrin (3 trials)

erythromycin (ilosone) (1 trial)

ethinyl estradiol (Estinyl) (1 trial)

guar gum (1 trial)

lactobacillus reuteri (1 trial)

metamizole (Novalgin) (3 trials)

neomycin (1 trial)

orange juice (2 trials)

sodium fluoride (18F) (1 trial)

stem cells (1 trial)

sun mushroom (1 trial)

triclosan (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Abdominal Pain (Phase 3)

Aggression (Phase 3)

Aggressive Periodontitis (Phase 3)

Anxiety Disorders (Phase 1)

Chronic Pain (Phase 4)

Cross Infection (Phase 2)

Dental Pulp Diseases (Phase 2)

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 1 (Phase 4)

Diabetic Neuropathies (Phase 4)

Dyspepsia (Phase 3)

Eunuchism (Phase 4)

Gastroesophageal Reflux (Phase 3)

HIV Infections (Phase 4)

Hypogonadism (Phase 4)

Inflammation (Phase 2)

Keratosis (Phase 2)

Keratosis, Actinic (Phase 2)

Kidney Diseases (Phase 2)

Malabsorption Syndromes (Phase 3)

Mucopolysaccharidoses (Phase 3)

Mucopolysaccharidosis II (Phase 3)

Neuralgia (Phase 4)

Pain, Postoperative (Phase 4)

Periodontitis (Phase 4)

Pneumonia (Phase 4)

Renal Insufficiency (Phase 4)

Renal Insufficiency, Chronic (Phase 2)

Stomatitis (Phase 2)

Stomatitis, Denture (Phase 2)

Syndrome (Phase 3)

Telangiectasis (Phase 4)

Varicose Veins (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 50
  • # of Trial APIs: 64